The pursuit of safer, more effective drugs continues to be one of the most pressing challenges in th...
The global burden of liver disease continues to rise, and currently accounts for approximately two m...
In this interview, Marketing Manager Haris Choudhery, PhD, sat down with Head of R&D Nikolaos Ni...
Our phenotypic screening services help you move quickly and efficiently from screening to identifyin...
Understanding Metabolic dysfunction-associated steatotic Liver disease (MASLD) Metabolic dysfunction...
Table of Contents Understanding PFIC and PFIC2 The Challenge in Pre-Clinical Models The advantages o...
A considerable roadblock in the successful triaging of new therapeutics for liver and metabolic-rela...
Alpha-1-antitrypsin deficiency (A1ATD) is a monogenic inherited liver disease with 180,000 individua...
Have you ever wondered how DefiniGEN’s proprietary OptiDIFF technology gives them a competitive adva...